Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -45.21% vs -14.10% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 63.74% vs -72.28% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 19.81% vs 26.12% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 37.14% vs -36.55% in Mar 2025
Compare Profit and Loss Results of Krebs Biochem
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
23.00
80.00
-57.00
-71.25%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
23.00
80.00
-57.00
-71.25%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
69.00
-69.00
-100.00%
Power & Fuel Cost
9.00
0.00
9.00
0%
Employee Cost
10.00
5.00
5.00
100.00%
Operating Expenses
2.00
0.00
2.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
0.00
2.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
29.00
79.00
-50.00
-63.29%
Operating Profit (PBDIT) excl Other Income
-5.00
0.00
-5.00
0%
Other Income
2.00
9.00
-7.00
-77.78%
Operating Profit (PBDIT)
-3.00
10.00
-13.00
-130.00%
Interest
7.00
2.00
5.00
250.00%
Profit before Depriciation and Tax
-10.00
7.00
-17.00
-242.86%
Depreciation
6.00
0.00
6.00
0%
Profit Before Taxation & Exceptional Items
-16.00
7.00
-23.00
-328.57%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-16.00
7.00
-23.00
-328.57%
Provision for Tax
0.00
1.00
-1.00
-100.00%
Profit After Tax
-16.00
5.00
-21.00
-420.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
-297.00
59.00
-356.00
-603.39%
Profit Available for appropriations
-314.00
64.00
-378.00
-590.62%
Appropriations
-314.00
64.00
-378.00
-590.62%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-7.85
0.93
-8.78
-944.09%
Profit And Loss - Net Sales
Net Sales 23.73 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -45.21% vs -14.10% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -5.45 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 63.74% vs -72.28% in Mar 2025
Profit And Loss - Interest
Interest 7.09 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 19.81% vs 26.12% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax -16.93 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 37.14% vs -36.55% in Mar 2025
Footer loading
